TELEFLEX INCTFXEarnings & Financial Report
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with...
Revenue
$700.7M
Gross Profit
$389.4M
Operating Profit
$125.6M
Net Profit
$95.0M
Gross Margin
55.6%
Operating Margin
17.9%
Net Margin
13.6%
YoY Growth
-5.0%
EPS
$2.07
Financial Flow
TELEFLEX INC Q1 2025 Financial Summary
TELEFLEX INC reported revenue of $700.7M (down 5.0% YoY) for Q1 2025, with a net profit of $95.0M (up 521.4% YoY) (13.6% margin). Cost of goods sold was $311.2M, operating expenses totaled $263.9M.
Key Financial Metrics
| Total Revenue | $700.7M |
|---|---|
| Net Profit | $95.0M |
| Gross Margin | 55.6% |
| Operating Margin | 17.9% |
| Report Period | Q1 2025 |
Revenue Breakdown
TELEFLEX INC Q1 2025 revenue of $700.7M breaks down across 7 segments, led by Vascular Access at $182.4M (26.0% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Vascular Access | $182.4M | 26.0% |
| Interventional | $137.6M | 19.6% |
| Surgical | $105.8M | 15.1% |
| Anesthesia | $86.6M | 12.4% |
| Interventional Urology | $71.0M | 10.1% |
| Oem | $63.9M | 9.1% |
| Other | $53.5M | 7.6% |
TELEFLEX INC Revenue by Segment — Quarterly Trend
TELEFLEX INC revenue by segment across the last 4 reported quarters, showing how each business line (such as Vascular Access and Interventional) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Vascular Access | — | $191.0M | $185.5M | $182.4M |
| Interventional | — | $266.4M | $170.0M | $137.6M |
| Surgical | — | $122.9M | $114.0M | $105.8M |
| Anesthesia | — | $101.4M | $96.4M | $86.6M |
| Interventional Urology | — | $71.8M | $76.4M | $71.0M |
TELEFLEX INC Annual Revenue by Year
TELEFLEX INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.0B).
| Year | Annual Revenue |
|---|---|
| 2025 | $2.0B |
| 2024 | $3.0B |
| 2022 | $2.8B |
TELEFLEX INC Quarterly Revenue & Net Profit History
TELEFLEX INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $-401.9M | -150.5% | $-714.3M | 177.8% |
| Q3 2025 | $913.0M | +19.4% | $-408.9M | -44.8% |
| Q2 2025 | $780.9M | +4.2% | $122.6M | 15.7% |
| Q1 2025 | $700.7M | -5.0% | $95.0M | 13.6% |
| Q4 2024 | $795.4M | +6.6% | $-136.7M | -17.2% |
| Q3 2024 | $764.4M | +2.8% | $111.0M | 14.5% |
| Q2 2024 | $749.7M | +5.5% | $80.0M | 10.7% |
| Q1 2024 | $737.8M | — | $15.3M | 2.1% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $737.8M | $749.7M | $764.4M | $795.4M | $700.7M | $780.9M | $913.0M | $-401.9M |
| YoY Growth | N/A | 5.5% | 2.8% | 6.6% | -5.0% | 4.2% | 19.4% | -150.5% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $7.48B | $7.44B | $7.49B | $7.10B | $7.16B | $7.38B | $7.87B | $6.95B |
| Liabilities | $2.97B | $2.88B | $3.00B | $2.82B | $3.07B | $3.13B | $4.05B | $3.82B |
| Equity | $4.50B | $4.56B | $4.48B | $4.28B | $4.10B | $4.24B | $3.82B | $3.12B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $112.8M | $91.7M | $231.1M | $202.6M | $73.3M | $7.8M | $107.8M | $-92.3M |